A news feature follows former NFL player Robert Gallery and his long struggle with cognitive and emotional symptoms linked to repeated head trauma sustained during his football career. After years of depression, memory problems, and substance use, Gallery traveled to Mexico in 2021 to undergo treatment with ibogaine, a psychoactive compound derived from a West African plant. He reports experiencing significant improvements following the treatment and says the changes have continued in the years since.
The story places Gallery’s experience within the broader conversation about emerging treatments for traumatic brain injury, addiction, and mental health conditions. Researchers are studying how ibogaine may affect neuroplasticity and brain function, while advocates and policymakers continue to push for regulated clinical trials in the United States to better understand its potential benefits and risks.